Citius Pharmaceuticals Inc CTXR:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 2:05 PM EDT
1.22quote price arrow down-0.05 (-3.94%)
Volume
537,257
52 week range
0.83 - 2.35
Loading...
  • Open1.24
  • Day High1.27
  • Day Low1.20
  • Prev Close1.27
  • 52 Week High2.35
  • 52 Week High Date08/30/21
  • 52 Week Low0.83
  • 52 Week Low Date06/21/22

Key Stats

  • Market Cap178.28M
  • Shares Out146.13M
  • 10 Day Average Volume0.97M
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • YTD % Change-21.14

KEY STATS

  • Open1.24
  • Day High1.27
  • Day Low1.20
  • Prev Close1.27
  • 52 Week High2.35
  • 52 Week High Date08/30/21
  • 52 Week Low0.83
  • 52 Week Low Date06/21/22
  • Market Cap178.28M
  • Shares Out146.13M
  • 10 Day Average Volume0.97M
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • YTD % Change-21.14

RATIOS/PROFITABILITY

  • EPS (TTM)-0.21
  • P/E (TTM)-5.82
  • Fwd P/E (NTM)-12.20
  • EBITDA (TTM)-30.967M
  • ROE (TTM)-24.84%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date12/13/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Citius Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Citius Pharmaceuticals Inc. specialty pharmaceutical company. The Company develops and commercializes critical care products with a focus on anti-infective products in adjunct cancer care, prescription products and mesenchymal stem cell therapy. It has five products: Mino-Lok, Mino-Wrap, Halo-Lido, NoveCite and I/ONTAK. Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. Mino-Wrap is a...
Leonard Mazur
Executive Chairman of the Board, Chief Executive Officer, Company Secretary
Myron Holubiak
Executive Vice Chairman of the Board
Jaime Bartushak
Chief Financial Officer, Chief Business Officer
Myron Czuczman M.D.
Chief Medical Officer, Executive Vice President
Michael McGuire
Vice President, Program Leader for Anti-Infectives
Address
11 Commerce Dr Fl 1
Cranford, NJ
07016-3501
United States

Top Peers

SYMBOLLASTCHG%CHG
INMB
INmune Bio Inc
9.18-0.22-2.39%
SBTX
Silverback Therapeutics Inc
5.44+0.05+0.93%
OLMA
Olema Pharmaceuticals Inc
3.96-0.31-7.26%
GMDA
Gamida Cell Ltd
3.32+0.09+2.79%
CVM
CEL-SCI Corp
4.57-0.05-1.08%